A spike in the number of women taking stimulants for attention disorders is raising concern among doctors about the potential impact on pregnancy.
Federal health officials on Thursday reported a 344 percent increase since 2003 in women between the ages of 15 and 44 who filled prescriptions for stimulants and other medications to treat attention deficit/hyperactivity disorder (ADHD). The increase was greatest, 700 percent, among women 25 to 29. The report, by the U.S. Centers for Disease Control and Prevention, covered women with private insurance.
Minnesota doctors said that increase has translated into more patients who are pregnant and have ADHD, which has been challenging because there is no clear medical guidance on whether to keep them on the drugs or not.
"This was not something we saw very commonly among pregnant women 10 years ago," said Dr. Elizabeth Baldwin, a maternal-fetal specialist with Minnesota Perinatal Physicians.
A few studies have linked stimulants such as Adderall and Ritalin with elevated rates of birth defects, but they aren't definitive. A study published in the journal Pediatrics last fall, for example, found more seizures among newborns who had been exposed during pregnancy to ADHD medications, but it couldn't prove that the medications were at fault.
Physicians and their patients need research to address the question because the early stages of pregnancy are key for fetal development, said Coleen Boyle, a CDC specialist on birth defects and developmental disabilities.
"Half of all pregnancies in the United States are unplanned, and women may be taking prescription medicine early in pregnancy before they know they are pregnant," she said.
Mackenzie Mestelle, a Minneapolis mental health worker, said she struggles to stay on time and plan and cook meals each day — even though she takes ADHD medications. But Mestelle, 29, figures she would quit the drugs anyway if she gets pregnant.